Scientific Publications

Explore the scientific evidence for the Veracyte Diagnostics Platform, including peer-reviewed publications, conference posters, and abstracts.

Filter By

Disease Area
OR
Technology
Type
Journal/Conference
Year
Sort by

Publications

Action
Development of novel mRNA classifiers to stratify preoperative thyroid tumor risk
 Afirma Thyroid
Otolaryngol Head Neck Surg
 2026 Discovery View
Bridging and analytical validation of the Prosigna Breast Risk of Recurrence Test as a whole-transcriptome NGS lab developed test
 Prosigna Breast
medRxiv
 2026 Preprint, Validation View
Preoperative Risk Stratification of Differentiated Thyroid Carcinoma Using a Molecular Cell Cycle Progression Score: Association with American Thyroid Association (ATA) Risk of Recurrence
 Afirma Thyroid
ENDO
 2026 Conferences View
High folate receptor expression is associated with aggressive features in prostate cancer with low prostate-specific membrane antigen expression
 Decipher Prostate GRID
BJUI Compass
 2026 Discovery View
Neoadjuvant Sacituzumab Govitecan in Patients With Muscle-Invasive Bladder Cancer: Primary Results of the SURE-01 Trial
 Decipher Bladder
J Clin Oncol
 2026 Discovery View
Characterizing the Activity of Inflammasome-Related Genes and Their Association with Oncological Outcomes in Prostate Cancer
 Decipher Prostate GRID
Prostate
 2026 Discovery View
Development of an extended version of GALEAS bladder: Detection of FGFR3 fusions in urine and associations between genomic alterations and gene expression
 Decipher Bladder GRID
Bladder Cancer
 2026 Discovery View
Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancer
 Decipher Prostate GRID
J Immunother Cancer
 2026 Discovery View
Analysis of PLEKHS1 Promoter Mutations in Preoperative Thyroid Nodule Samples
 Afirma GRID
Cancer Cytopathol
 2026 Conferences View
The role of HAI-1 in urothelial bladder cancer: Tissue expression, ectodomain shedding and clinical outcomes
 Decipher Bladder GRID
Biochem Biophys Rep
 2026 Discovery View
Understanding randomized controlled trial generalizability through an embedded molecular diagnostics trial
 Decipher Prostate
JNCI Cancer Spectr
 2026 Validation View
Preoperative mRNA Expression Signatures Associated with 2025 American Thyroid Association (ATA) Risk of Recurrence Categories
 Afirma Thyroid
AACE
 2026 Conferences View
Molecular Characterization of Upper Pole Thyroid Nodules
 Afirma Thyroid
AACE
 2026 Conferences View
Risk of Structural Disease Recurrence Reclassification of Differentiated Thyroid Cancer from 2015 to 2025 American Thyroid Association (ATA) Guidelines
 Afirma Thyroid
AACE
 2026 Conferences View
Correlation between histologic features and Decipher genomic risk in prostate cancer biopsies
 Decipher Prostate
Ann Diagn Pathol
 2026 Validation View
Carboplatin, Cabazitaxel, and Abiraterone in High-Volume Metastatic Castration-Sensitive Prostate Cancer: The CASCARA Phase II Study
 Decipher Prostate
Clin Cancer Res
 2026 Discovery View
Afirma GSC and mRNA Expression Features in Bethesda III Thyroid Nodules
 Afirma Thyroid
USCAP
 2026 Conferences View
Prediction of molecular subtypes from histology: AI-driven analysis of prostate cancer morphological patterns and therapeutic implications
 Decipher Prostate GRID
NPJ Precision Oncology
 2026 Discovery View
Integration of Habitat Risk Score in Radiation Therapy for Prostate Cancer
 Decipher Prostate
Int J Radiat Oncol Biol Phys
 2026 Discovery View
A Pilot Study of 18F-rhPSMA-7.3-PET/MRI to Reduce Mischaracterization of Active Surveillance and Focal Therapy Candidates With Occult Higher Risk Disease
 Decipher Prostate
Prostate
 2026 Discovery View

Showing 1–20 of 495 results

GRID Research Platform: accelerating cancer discovery through collaboration

Enabling breakthrough discoveries through our expansive curated genomic databases in cancer research.

The Genomic Resource for Intelligent Discovery (GRID) provides researchers with comprehensive whole-transcriptome databases and clinical data to accelerate cancer discoveries. Currently available for urologic and thyroid cancers, GRID enables collaborative research that advances our collective understanding of cancer biology and treatment optimization.

Explore Decipher GRID Explore Afirma GRID

Keep exploring

Veracyte Diagnostics Platform

A novel diagnostics platform helping unlock deeper cancer insights.

Discover

Clinical Studies

Studies demonstrating the impact of our tests across cancer types.

Discover

About Us

The team, our values, mission, and approach.

Learn More

Blog

Inspiring stories and latest clinical advances.

Learn More

Let’s connect

Our Medical Science Liaisons (MSLs) are field-based scientific experts equipped for in-depth discussions on our tests and how they can support your practice needs.

Contact Us